arsenic trioxide has been researched along with Chromosomal Duplication in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, J; Jin, J; Lou, Y; Ma, Y; Mai, W; Mao, L; Meng, H; Ni, W; Pan, H; Qian, W; Suo, S; Tong, H; Wang, Y; Wei, J; Yu, W | 1 |
1 other study(ies) available for arsenic trioxide and Chromosomal Duplication
| Article | Year |
|---|---|
Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; CD56 Antigen; Chromosome Duplication; Female; fms-Like Tyrosine Kinase 3; Gene Expression; Humans; Injections, Intravenous; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Multivariate Analysis; Oncogene Proteins, Fusion; Oxides; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis | 2015 |